The impact of low levels of amorphous material (<5%) on the blending characteristics of a direct compression formulation

被引:48
作者
Mackin, L
Sartnurak, S
Thomas, I
Moore, S
机构
[1] Pharmacia, QA Dept, Morpeth, Northants, England
[2] Pharmacia, Proc Dev, Morpeth, Northants, England
[3] Pharmacia R&D, Pharmaceut & Analyt Sci, Skokie, IL 60077 USA
关键词
milling; amorphous; blend content uniformity; surface properties; dynamic vapour sorption; isothermal microcalorimetry;
D O I
10.1016/S0378-5173(01)00880-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the manufacture of tablets for registration stability studies, it was observed that blends manufactured using milled active frequently failed the blend content uniformity criteria (actual relative standard deviation (RSD) of 4-15%) at the prelubrication stage, whereas unmilled active batches were consistently giving very good blend uniformity results (RSD <3.5%). The addition of magnesium stearate dramatically improved the blending characteristics of the milled batches, suggesting that milling had altered the surface properties. A hypothesis was presented that amorphous material was created during the milling of the active batches, which subsequently recrystallised over a short period of time e.g. days/hours. Following recrystallisation the batches did not exhibit the same physical properties as the unmilled actives, and this resulted in the drug product batches failing to meet their pre-lubrication acceptance criteria for blend content uniformity. This paper describes the results of a laboratory scale study to investigate this hypothesis and therefore explain the processing issues that were observed during the manufacture of the registration stability batches with milled active batches. (C) 2002 Elsevier science B.V. All rights reserved.
引用
收藏
页码:213 / 226
页数:14
相关论文
共 14 条
[1]   The use of isothermal microcalorimetry in the study of small degrees of amorphous content of a hydrophobic powder [J].
Ahmed, H ;
Buckton, G ;
Rawlins, DA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 130 (02) :195-201
[2]   LACTOSE AND THERMAL-ANALYSIS WITH SPECIAL EMPHASIS ON MICROCALORIMETRY [J].
ANGBERG, M .
THERMOCHIMICA ACTA, 1995, 248 :161-176
[3]  
ASO Y, 1995, CHEM PHARM BULL, V43, P300
[4]   THE USE OF ISOTHERMAL MICROCALORIMETRY IN THE STUDY OF CHANGES IN CRYSTALLINITY INDUCED DURING THE PROCESSING OF POWDERS [J].
BRIGGNER, LE ;
BUCKTON, G ;
BYSTROM, K ;
DARCY, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 105 (02) :125-135
[5]   THE USE OF GRAVIMETRIC STUDIES TO ASSESS THE DEGREE OF CRYSTALLINITY OF PREDOMINANTLY CRYSTALLINE POWDERS [J].
BUCKTON, G ;
DARCY, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 123 (02) :265-271
[6]   Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations [J].
Buckton, G .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 26 (01) :17-27
[7]   The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems [J].
Craig, DQM ;
Royall, PG ;
Kett, VL ;
Hopton, ML .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (02) :179-207
[8]   Determination of surface properties and how characteristics of salbutamol sulphate, before and after micronisation [J].
Feeley, JC ;
York, P ;
Sumby, BS ;
Dicks, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 172 (1-2) :89-96
[9]   ASSESSMENT OF DISORDER IN CRYSTALLINE SOLIDS [J].
SALEKIGERHARDT, A ;
AHLNECK, C ;
ZOGRAFI, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 101 (03) :237-247
[10]   ASSESSMENT OF THE DEGREE OF DISORDER IN CRYSTALLINE SOLIDS BY ISOTHERMAL MICROCALORIMETRY [J].
SEBHATU, T ;
ANGBERG, M ;
AHLNECK, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (02) :135-144